Chronic Phase Chronic Myelogenous Leukemia Completed Phase 2 Trials for Antithymocyte immunoglobulin (rabbit) (DB00098)

DBCOND0028870 (Chronic Phase Chronic Myelogenous Leukemia)Completed2 IdentifierTitlePurposeDrugs
NCT01093586Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesTreatment
NCT01056614Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid MalignanciesTreatment